These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 19403931)

  • 1. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
    Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
    Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA; Kyle RA; O'Fallon WM
    Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
    Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F
    Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of urinary protein in primary systemic amyloidosis (AL).
    Gertz MA; Kyle RA
    Am J Clin Pathol; 1990 Sep; 94(3):313-7. PubMed ID: 2118721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
    Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
    Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival].
    Esteve V; Almirall J; Ponz E; García N; Ribera L; Larrosa M; Andreu X; García M
    Nefrologia; 2006; 26(2):212-7. PubMed ID: 16808259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
    Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
    Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.
    Eirin A; Irazabal MV; Gertz MA; Dispenzieri A; Lacy MQ; Kumar S; Sethi S; Nasr SH; Cornell LD; Fidler ME; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2012 Mar; 27(3):1097-101. PubMed ID: 22067518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival of myeloma patients treated with dialysis].
    Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E
    Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.